The Miami Project to Cure Paralysis   Report issue

Foundation Phase 1
Founded: Miami FL United States (1985)

Organization Overview

First Clinical Trial
2012
NCT01739023
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

The Miami Project to Cure Paralysis

Active Ingredients

Drugs in Phase 1 Trials (1)

autologous human schwann cells (5 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Paraplegia (Phase 1)

Peripheral Nerve Injuries (Phase 1)

Quadriplegia (Phase 1)

Spinal Cord Injuries (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 5
  • # of Trial APIs: 1